Results 301 to 310 of about 425,990 (360)

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source

Oral Health and Diabetic Cardiomyopathy: Mechanisms, Biomarkers, and Early Screening Approaches. [PDF]

J Inflamm Res
Fang J, Wu Y, Wang H, Zhang J, You L.
europepmc   +1 more source

Atrial cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala, Monika Przewłocka‐Kosmala   +1 more
wiley   +1 more source

Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy

ESC Heart Failure, EarlyView.
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio, Andrea Silvio Giordani, Stefania Rizzo, Cristina Vicenzetto, Monica De Gaspari, Elisa Carturan, Giuseppe Toscano, Federico Scognamiglio, Giuseppe Tarantini, Sabino Iliceto, Cristina Basso, Renzo Marcolongo, Alida Linda Patrizia Caforio   +12 more
wiley   +1 more source

Stem cells in the treatment of myocardial injury-induced cardiomyopathy: mechanisms and efficient utilization strategies. [PDF]

Front Pharmacol
Yang J, Yue T, He J, Xiong S, Luo Y, Hou J.   +5 more
europepmc   +1 more source

Analysis of outcomes in patients with HeartMate 3 with and without right ventricular assist device support

ESC Heart Failure, EarlyView.
Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau, Laura Coyle, Rachel Pedersen, Colleen Gallagher, Nicole Graney, Lisa Kukla, Robin Paliga, Gregory P. Macaluso, Sunil Pauwaa, William G. Cotts, Patroklos S. Pappas, Antone J. Tatooles, Nikhil Narang   +12 more
wiley   +1 more source

The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy. [PDF]

Cells
Wang W, Gao Y, Lee HK, Yu AC, Kipp M, Kaddatz H, Zhan J.   +6 more
europepmc   +1 more source

Right ventricular global work efficiency: A reliable non‐invasive estimate of right ventricular contractility

ESC Heart Failure, EarlyView.
The figure illustrates the study design and key findings related to right ventricular myocardial work (RVMW) in heart failure with reduced ejection fraction (HFrEF) patients with and without pulmonary hypertension (PH). Patients were stratified into two groups: those with PH (n = 53) and those without PH (n = 49), as determined by right heart ...
Paolo Manca, Vincenzo Nuzzi, Alessandro Lucchino, Gerardo Rugiano, Massimiliano Mulè, Alessandra Carvelli, Stefano Cannata, Sergio Sciacca, Francesca Parisi, Sabato Sorrentino, Francesco Fulvio Faletra, Paolo C. Colombo, Manlio Gianni Cipriani   +12 more
wiley   +1 more source

Catheter Ablation of Right Ventricular Endocavitary Arrhythmias. [PDF]

JACC Adv
Haq IU, Ezzeddine FM, Al-Shakarchi N, Asirvatham SJ, Del-Carpio Munoz F, Deshmukh AJ, DeSimone CV, Friedman PA, Kowlgi GN, Madhavan M, Noseworthy PA, Kapa S, Siontis KC, Tan NY, Sugrue A, Killu AM.   +15 more
europepmc   +1 more source

Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist device

ESC Heart Failure, EarlyView.
Abstract Aims Donation after circulatory death (DCD) has emerged as a strategy to increase the donor pool for heart transplantation (HT). Left ventricular assist device (LVAD) patients represent a discrete and unique population. We sought to explore the early outcomes of DCD‐HT compared with donation after brain death (DBD) HT in LVAD patients. Methods
Aris Karatasakis, Edwin Grajeda Silvestri, Gatha G. Nair, Benjamin Zuniga, Song Li, Claudius Mahr, Richard K. Cheng, April S. Stempien‐Otero, Ioannis Dimarakis, Maziar Khorsandi, Jay D. Pal, Jorge R. Kizer, Marc A. Simon, Claudio A. Bravo   +13 more
wiley   +1 more source